Treatment of MRSA Mastitis in Lactating Women

Initial Management Approach

Incision and drainage is the primary treatment for any abscess formation associated with mastitis in lactating women, and is recommended by the Infectious Diseases Society of America 1, 2

Clindamycin (600 mg orally three times daily) is the preferred first-line antibiotic treatment for MRSA mastitis in lactating women, as recommended by the American Academy of Pediatrics, due to its effectiveness against MRSA and safety profile during lactation 1, 2, 3
Trimethoprim-sulfamethoxazole (TMP-SMX) plus amoxicillin is an alternative option for MRSA mastitis in lactating women, but TMP-SMX should be avoided in the third trimester of pregnancy and in infants younger than 2 months, as advised by the Centers for Disease Control and Prevention 2, 3, 5
Linezolid (600 mg orally twice daily) is effective as a single agent against both MRSA and streptococci, but its use in lactating women should be cautious due to its transfer into breast milk, as noted by the Mayo Clinic 2, 3
Tetracyclines (doxycycline, minocycline) are generally avoided during lactation due to potential developmental impacts on the infant, as recommended by the American College of Obstetricians and Gynecologists 4

Intravenous vancomycin is the recommended treatment for complicated MRSA mastitis with systemic symptoms or abscess formation, as recommended by the Infectious Diseases Society of America 2, 6

Obtaining cultures from purulent drainage before starting antibiotics is crucial to confirm MRSA and guide therapy, as advised by the Centers for Disease Control and Prevention 1, 7
Beta-lactam antibiotics are generally safe during lactation but ineffective against MRSA, as noted by the Mayo Clinic 4

Keeping any draining wounds covered with clean, dry bandages, maintaining good personal hygiene with regular handwashing, and focusing cleaning on high-touch surfaces can help reduce the risk of MRSA recurrence, as recommended by the Centers for Disease Control and Prevention 7, 8